BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moayyedi P, Soo S, Deeks J, Forman D, Harris A, Innes M, Delaney B. Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther. 2003;17:1215-1227. [PMID: 12755835 DOI: 10.1046/j.1365-2036.2003.01575.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Banihani SA. Histamine-2 Receptor Antagonists and Semen Quality. Basic Clin Pharmacol Toxicol 2016;118:9-13. [DOI: 10.1111/bcpt.12446] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
2 Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005;129:1756-1780. [PMID: 16285971 DOI: 10.1053/j.gastro.2005.09.020] [Cited by in Crossref: 278] [Cited by in F6Publishing: 216] [Article Influence: 17.4] [Reference Citation Analysis]
3 Herbert MK, Holzer P. Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients--current status and future options. Clin Nutr. 2008;27:25-41. [PMID: 17933437 DOI: 10.1016/j.clnu.2007.08.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
4 Mcnally MA, Talley NJ. Current treatments in functional dyspepsia. Curr Treat Options Gastro 2007;10:157-68. [DOI: 10.1007/s11938-007-0068-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Saito YA, Locke GR, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR, Talley NJ. Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. Am J Gastroenterol 2017;112:903-9. [PMID: 28291238 DOI: 10.1038/ajg.2017.52] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kleibeuker JH, Thijs JC. Functional dyspepsia. Curr Opin Gastroenterol. 2004;20:546-550. [PMID: 15703680 DOI: 10.1097/00001574-200411000-00007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
7 Trukhmanov AS, Ivashkina NY. The clinical significance of disorders of the motor function of the esophagus, stomach and duodenum. Terapevticheskii arkhiv 2019;91:127-34. [DOI: 10.26442/00403660.2019.08.000390] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Oh JH, Kwon JG, Jung HK, Tae CH, Song KH, Kang SJ, Kim SE, Jung K, Kim JS, Park JK, Bang KB, Baeg MK, Shin JE, Shin CM, Lee JY, Lim HC; Functional Dyspepsia Research Group and Clinical Practice Guidelines Group Under the Korean Society of Neurogastroenterology and Motility. Clinical Practice Guidelines for Functional Dyspepsia in Korea. J Neurogastroenterol Motil 2020;26:29-50. [PMID: 31917913 DOI: 10.5056/jnm19209] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
9 Talley NJ. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology. 2005;129:1753-1755. [PMID: 16285970 DOI: 10.1053/j.gastro.2005.09.019] [Cited by in Crossref: 94] [Cited by in F6Publishing: 79] [Article Influence: 5.9] [Reference Citation Analysis]
10 Barton PM, Moayyedi P, Talley NJ, Vakil NB, Delaney BC. A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States. Med Decis Making 2008;28:44-55. [PMID: 18057189 DOI: 10.1177/0272989X07309644] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
11 Fox MR, Kahrilas PJ, Roman S, Gyawali CP, Scott SM, Rao SS, Keller J, Camilleri M; International Working Group for Disorders of Gastrointestinal Motility and Function. Clinical measurement of gastrointestinal motility and function: who, when and which test? Nat Rev Gastroenterol Hepatol 2018;15:568-79. [PMID: 29872118 DOI: 10.1038/s41575-018-0030-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
12 Soo S, Forman D, Delaney BC, Moayyedi P. A systematic review of psychological therapies for nonulcer dyspepsia. Am J Gastroenterol. 2004;99:1817-1822. [PMID: 15330925 DOI: 10.1111/j.1572-0241.2004.30086.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
13 Halder SL, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2005;8:325-336. [PMID: 16009034 DOI: 10.1007/s11938-005-0026-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
14 Hojo M, Miwa H, Yokoyama T, Ohkusa T, Nagahara A, Kawabe M, Asaoka D, Izumi Y, Sato N. Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol. 2005;40:1036-1042. [PMID: 16322947 DOI: 10.1007/s00535-005-1687-8] [Cited by in Crossref: 78] [Cited by in F6Publishing: 56] [Article Influence: 4.9] [Reference Citation Analysis]
15 Singh H, Bala R, Kaur K. Efficacy and tolerability of levosulipride, domperidone and metoclopramide in patients with non-ulcer functional dyspepsia: a comparative analysis. J Clin Diagn Res. 2015;9:FC09-FC12. [PMID: 26023567 DOI: 10.7860/jcdr/2015/11613.5775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
16 Brun R, Kuo B. Functional dyspepsia. Therap Adv Gastroenterol 2010;3:145-64. [PMID: 21180597 DOI: 10.1177/1756283X10362639] [Cited by in Crossref: 65] [Cited by in F6Publishing: 33] [Article Influence: 5.9] [Reference Citation Analysis]
17 Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology. 2004;127:1329-1337. [PMID: 15521002 DOI: 10.1053/j.gastro.2004.08.026] [Cited by in Crossref: 159] [Cited by in F6Publishing: 135] [Article Influence: 8.8] [Reference Citation Analysis]
18 Carbone F, Holvoet L, Vandenberghe A, Tack J. Functional dyspepsia: outcome of focus groups for the development of a questionnaire for symptom assessment in patients suffering from postprandial distress syndrome (PDS). Neurogastroenterol Motil 2014;26:1266-74. [DOI: 10.1111/nmo.12381] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
19 Patrick A, Epstein O. Review article: gastroparesis. Aliment Pharmacol Ther. 2008;27:724-740. [PMID: 18248660 DOI: 10.1111/j.1365-2036.2008.03637.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
20 Moayyedi P. Meta-analysis: Can we mix apples and oranges? Am J Gastroenterol. 2004;99:2297-2301. [PMID: 15571572 DOI: 10.1111/j.1572-0241.2004.40948.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
21 Suzuki H, Moayyedi P. Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013;10:168-174. [PMID: 23358394 DOI: 10.1038/nrgastro.2013.9] [Cited by in Crossref: 103] [Cited by in F6Publishing: 85] [Article Influence: 11.4] [Reference Citation Analysis]
22 Tack J. The difficult patient with gastroparesis. Best Practice & Research Clinical Gastroenterology 2007;21:379-91. [DOI: 10.1016/j.bpg.2007.01.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
23 Kandulski A, Venerito M, Malfertheiner P. Therapeutic strategies for the treatment of dyspepsia. Expert Opin Pharmacother 2010;11:2517-25. [PMID: 20726822 DOI: 10.1517/14656566.2010.501794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Oh JH, Kwon JG. [Functional Dyspepsia]. Korean J Gastroenterol 2019;73:77-83. [PMID: 30845383 DOI: 10.4166/kjg.2019.73.2.77] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Yamamichi N, Shimamoto T, Sakaguchi Y, Takahashi Y, Kodashima S, Nakayama C, Minatsuki C, Ono S, Mochizuki S, Matsuda R, Asada-Hirayama I, Niimi K, Fujishiro M, Tsuji Y, Takeuchi C, Kakimoto H, Goto O, Mitsushima T, Koike K. Categorization of upper gastrointestinal symptoms is useful in predicting background factors and studying effects and usages of digestive drugs. PLoS One 2014;9:e88277. [PMID: 24505461 DOI: 10.1371/journal.pone.0088277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 di Mario F, Stefani N, Bò ND, Rugge M, Pilotto A, Cavestro GM, Cavallaro LG, Franzé A, Leandro G. Natural course of functional dyspepsia after Helicobacter pylori eradication: a seven-year survey. Dig Dis Sci 2005;50:2286-95. [PMID: 16416176 DOI: 10.1007/s10620-005-3049-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
27 Moayyedi P. Who Pays the Piper? Journal of Clinical Gastroenterology 2007;41:S97-S101. [DOI: 10.1097/mcg.0b013e31803238e7] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
28 Banihani SA, Al-Natsheh AJ. Ranitidine decreases human sperm motility and vitality and increases the activity of seminal creatine kinase. Andrologia 2022;:e14436. [PMID: 35420703 DOI: 10.1111/and.14436] [Reference Citation Analysis]
29 Moayyedi P. Dyspepsia. Curr Opin Gastroenterol 2012;28:602-7. [PMID: 22918384 DOI: 10.1097/MOG.0b013e328358ad9b] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
30 Bazelle J, Threlfall A, Whitley N. Gastroprotectants in small animal veterinary practice - a review of the evidence. Part 1: cyto-protective drugs. J Small Anim Pract 2018. [PMID: 29974466 DOI: 10.1111/jsap.12867] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Stein J, Rösch W. H2-Blocker und Antazida bei gastrointestinalen Erkrankungen. Erfolgreiche Therapie von Ulcusleiden? Pharm Unserer Zeit 2007;36:38-43. [DOI: 10.1002/pauz.200600203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004;19:643-654. [PMID: 15023166 DOI: 10.1111/j.1365-2036.2004.01897.x] [Cited by in Crossref: 217] [Cited by in F6Publishing: 188] [Article Influence: 12.1] [Reference Citation Analysis]
33 Seyedmirzaei SM, Haghdoost AA, Afshari M, Dehghani A. Prevalence of dyspepsia and its associated factors among the adult population in southeast of iran in 2010. Iran Red Crescent Med J 2014;16:e14757. [PMID: 25763207 DOI: 10.5812/ircmj.14757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
34 Shaukat A, Wang A, Acosta RD, Bruining DH, Chandrasekhara V, Chathadi KV, Eloubeidi MA, Fanelli RD, Faulx AL, Fonkalsrud L, Gurudu SR, Kelsey LR, Khashab MA, Kothari S, Lightdale JR, Muthusamy VR, Pasha SF, Saltzman JR, Yang J, Cash BD, DeWitt JM; ASGE Standards of Practice Committee. The role of endoscopy in dyspepsia. Gastrointest Endosc 2015;82:227-32. [PMID: 26032200 DOI: 10.1016/j.gie.2015.04.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
35 Park CH, Kim HS, Lee SK. Effects of the New Prokinetic Agent DA-9701 Formulated With Corydalis Tuber and Pharbitis Seed in Patients With Minimal Change Esophagitis: A Bicenter, Randomized, Double Blind, Placebo-controlled Study. J Neurogastroenterol Motil 2014;20:338-46. [PMID: 24953714 DOI: 10.5056/jnm14019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
36 Blower PJ. 30  Inorganic pharmaceuticals. Annu Rep Prog Chem , Sect A: Inorg Chem 2004;100:633-58. [DOI: 10.1039/b312109g] [Cited by in Crossref: 25] [Article Influence: 1.4] [Reference Citation Analysis]
37 Carmona-Sánchez R, Gómez-Escudero O, Zavala-Solares M, Bielsa-Fernández MV, Coss-Adame E, Hernández-Guerrero AI, Huerta-Iga F, Icaza-Chávez ME, Lira-Pedrín MA, Lizárraga-López JA, López-Colombo A, Noble-Lugo A, Pérez-Manauta J, Raña-Garibay RH, Remes-Troche JM, Tamayo JL, Uscanga LF, Zamarripa-Dorsey F, Valdovinos Díaz MA, Velarde-Ruiz Velasco JA. Mexican consensus on dyspepsia. Rev Gastroenterol Mex 2017;82:309-27. [PMID: 28413079 DOI: 10.1016/j.rgmx.2017.01.001] [Reference Citation Analysis]
38 Talley NJ. What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther 2004;20 Suppl 2:23-30. [PMID: 15335410 DOI: 10.1111/j.1365-2036.2004.02043.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
39 Iwakiri R, Tominaga K, Furuta K, Inamori M, Furuta T, Masuyama H, Kanke K, Nagahara A, Haruma K, Kinoshita Y, Higuchi K, Takahashi S, Kusano M, Iwakiri K, Kato M, Hongo M, Hiraishi H, Watanabe S, Miwa H, Naito Y, Fujimoto K, Arakawa T. Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan. Aliment Pharmacol Ther 2013;38:729-40. [PMID: 23957383 DOI: 10.1111/apt.12444] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
40 Iwakiri R. Commentary: rabeprazole improves symptoms in patients with functional dyspepsia in Japan - author's reply. Aliment Pharmacol Ther 2013;38:1322-3. [PMID: 24134502 DOI: 10.1111/apt.12512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Dovjak P. [Duodenal ulcers, gastric ulcers and Helicobacter pylori]. Z Gerontol Geriatr 2017;50:159-69. [PMID: 28150170 DOI: 10.1007/s00391-017-1190-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
42 Portincasa P, Mearin F, Robert M, Plazas MJ, Mas M, Heras J. Eficacia y tolerabilidad de cinitaprida en el tratamiento de los pacientes con dispepsia funcional y vaciamiento gástrico enlentecido. Gastroenterología y Hepatología 2009;32:669-76. [DOI: 10.1016/j.gastrohep.2009.06.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
43 Saad RJ, Chey WD. Review article: current and emerging therapies for functional dyspepsia. Aliment Pharmacol Ther. 2006;24:475-492. [PMID: 16886913 DOI: 10.1111/j.1365-2036.2006.03005.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
44 Buzás GM. Quality of life in patients with functional dyspepsia: Short- and long-term effect of Helicobacter pylori eradication with pantoprazole, amoxicillin, and clarithromycin or cisapride therapy: A prospective, parallel-group study. Curr Ther Res Clin Exp 2006;67:305-20. [PMID: 24678104 DOI: 10.1016/j.curtheres.2006.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
45 Bramhall SR, Mourad MM. Is there still a role for sucralfate in the treatment of gastritis? World J Meta-Anal 2020; 8(1): 1-3 [DOI: 10.13105/wjma.v8.i1.1] [Reference Citation Analysis]
46 Talley NJ, Vakil N, Delaney B, Marshall B, Bytzer P, Engstrand L, de Boer W, Jones R, Malfertheiner P, Agréus L. Management issues in dyspepsia: current consensus and controversies. Scandinavian Journal of Gastroenterology 2009;39:913-8. [DOI: 10.1080/00365520410003452] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]